Cargando…

NI-10 CLINICAL BENEFITS FROM ONE-SHOT BEVACIZUMAB BEFORE A RESECTION OF GLIOBLASTOMA

PURPOSE: We aimed to clarify of clinical impacts from preoperative administration of bevacizumab (BEV) in patients with newly diagnosed glioblastoma. METHODS: Subjects were 17 patients who met the entry criteria, and were administered with BEV (10 mg/kg) one time before surgery. Between phases befor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Beppu, Takaaki, Sato, Yuichi, Nomura, Jyun-ichi, Fujiwara, Shunrou, Ogasawara, Kuniaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719337/ http://dx.doi.org/10.1093/noajnl/vdac167.064

Ejemplares similares

NI-11 PATHOLOGICAL ASSESSMENT IN THE IMPACT OF ONE-SHOT BEVACIZUMAB ON UPTAKE OF (11)C-METHIONINE
por: Beppu, Takaaki, et al.
Publicado: (2019)

Impacts on Histological Features and (11)C-Methyl-L-methionine Uptake After “One-Shot” Administration with Bevacizumab Before Surgery in Newly Diagnosed Glioblastoma()
por: Beppu, Takaaki, et al.
Publicado: (2019)

Detection of Retinal Hemangioblastomas in von Hippel–Lindau Disease Using Three-Dimensional Arterial Spin Labeling MR Imaging at 3T
por: Nomura, Jun-ichi, et al.
Publicado: (2016)

Apparent diffusion coefficient and arterial spin labeling perfusion of conventional chondrosarcoma in the parafalcine region: a case report
por: Kojima, Daigo, et al.
Publicado: (2017)

PET With (11)C-Methyl-l-Methionine as a Predictor of Consequential Outcomes at the Time of Discontinuing Temozolomide-Adjuvant Chemotherapy in Patients With Residual IDH-Mutant Lower-Grade Glioma
por: Beppu, Takaaki, et al.
Publicado: (2022)

NI-19 Use of (11)C-methionine PET for decision of discontinuation of adjuvant chemotherapy with temozolomide
por: Beppu, Takaaki, et al.
Publicado: (2020)

Relation between brain temperature and white matter damage in subacute carbon monoxide poisoning
por: Fujiwara, Shunrou, et al.
Publicado: (2016)

NI-13 Prediction of outcome at the time of discontinuing TMZ-adjuvant therapy in IDH-mutant lower grade glioma using (11)C-methinine PET
por: Beppu, Takaaki, et al.
Publicado: (2021)

Fractional anisotropy in the centrum semiovale as a quantitative indicator of cerebral white matter damage in the subacute phase in patients with carbon monoxide poisoning: correlation with the concentration of myelin basic protein in cerebrospinal fluid
por: Beppu, Takaaki, et al.
Publicado: (2012)

Feasibility and safety of partial resection of the anterior insular cortex for microsurgical treatment of middle cerebral artery aneurysms located in the limen recess: patient series
por: Akamatsu, Yosuke, et al.
Publicado: (2021)

Primary Cranial Vault Lymphoma Extending between Subcutaneous Tissue and Brain Parenchyma without Skull Destruction after Mild Head Trauma: A Case Report and Literature Review
por: Setta, Kengo, et al.
Publicado: (2021)

Utility of arterial spin labeling for objective assessment of intratumoral microvessels in diffuse hemispheric glioma, H3 G34R-mutant: A case report and literature review
por: Kitakami, Kei, et al.
Publicado: (2022)

Detection of misery perfusion in the cerebral hemisphere with chronic unilateral major cerebral artery steno-occlusive disease using crossed cerebellar hypoperfusion: comparison of brain SPECT and PET imaging
por: Matsumoto, Yoshiyasu, et al.
Publicado: (2013)

The Coefficient of Variation of Step Time Can Overestimate Gait Abnormality: Test-Retest Reliability of Gait-Related Parameters Obtained with a Tri-Axial Accelerometer in Healthy Subjects
por: Fujiwara, Shunrou, et al.
Publicado: (2020)

Histopathological investigation of glioblastomas resected under bevacizumab treatment
por: Tamura, Ryota, et al.
Publicado: (2016)

Cerebral Hyperperfusion after Revascularization Inhibits Development of Cerebral Ischemic Lesions Due to Artery-to-Artery Emboli during Carotid Exposure in Endarterectomy for Patients with Preoperative Cerebral Hemodynamic Insufficiency: Revisiting the “Impaired Clearance of Emboli” Concept
por: Fujimoto, Kentaro, et al.
Publicado: (2016)

Preoperative 3D FSE T1-Weighted MR Plaque Imaging for Severely Stenotic Cervical ICA: Accuracy of Predicting Emboli during Carotid Endarterectomy
por: Ogasawara, Yasushi, et al.
Publicado: (2016)

Wall Shear Stress and T1 Contrast Ratio Are Associated With Embolic Signals During Carotid Exposure in Endarterectomy
por: Oshida, Sotaro, et al.
Publicado: (2018)

Transient Symptomatic Downregulation of Cortical Neurotransmitter Receptor Function Due to Cerebral Hyperperfusion after Arterial Bypass Surgery for a Patient with Ischemic Moyamoya Disease
por: SHIMADA, Yasuyoshi, et al.
Publicado: (2018)

Biological Characteristics of a Cerebellar Mass Regrowing after Removal in a Patient with Lhermitte-Duclos Disease: Emission Tomography Studies
por: Saito, Hideo, et al.
Publicado: (2014)

Rupture of Vertebral Artery Dissecting Aneurysm after mRNA Anti-COVID-19 Vaccination: A Report of Two Cases
por: CHIDA, Kohei, et al.
Publicado: (2022)

Single-shot bevacizumab for cerebral radiation injury
por: Voss, Martin, et al.
Publicado: (2021)

High-uptake areas on positron emission tomography with the hypoxic radiotracer (18)F-FRP170 in glioblastomas include regions retaining proliferative activity under hypoxia
por: Beppu, Takaaki, et al.
Publicado: (2015)

Bevacizumab for glioblastoma
por: Narita, Yoshitaka
Publicado: (2015)

ANGI-01 ALTERATION IN IMMUNE REGULATORY CELLS BEFORE AND AFTER TREATMENT BY STUPP REGIMEN WITH OR WITHOUT BEVACIZUMAB FOR GLIOBLASTOMA
por: Tanaka, Toshihide, et al.
Publicado: (2019)

Bevacizumab for the Treatment of Glioblastoma
por: Gil-Gil, Miguel J., et al.
Publicado: (2013)

Bevacizumab in recurrent glioblastoma
por: Martinez, Nina L., et al.
Publicado: (2019)

Comparison of Subjective and Objective Assessments on Improvement in Gait Function after Carotid Endarterectomy
por: Takahashi, Tatsuhiko, et al.
Publicado: (2020)

Long-Term Cognitive Changes after Revascularization Surgery in Adult Patients with Ischemic Moyamoya Disease
por: Uchida, Shun, et al.
Publicado: (2021)

Intracranial aneurysm rupture within three days after receiving mRNA anti-COVID-19 vaccination: Three case reports
por: Oshida, Sotaro, et al.
Publicado: (2022)

Temozolomide and Bevacizumab Induction before Chemoradiotherapy in Patients with Bulky Glioblastoma and/or with Severe Neurological Impairment
por: Darmon, Ilan, et al.
Publicado: (2017)

Feasibility of IVIM parameters from diffusion-weighted imaging at 11.7T MRI for detecting ischemic changes in common carotid artery occlusion rats
por: Fujiwara, Shunrou, et al.
Publicado: (2020)

Bevacizumab for the Treatment of Recurrent Glioblastoma
por: Chamberlain, Marc C.
Publicado: (2011)

Persistent restoration to the immunosupportive tumor microenvironment in glioblastoma by bevacizumab
por: Tamura, Ryota, et al.
Publicado: (2018)

Superb Microvascular Imaging Ultrasound for Cervical Carotid Artery Stenosis for Prediction of the Development of Microembolic Signals on Transcranial Doppler during Carotid Exposure in Endarterectomy
por: Chiba, Takayuki, et al.
Publicado: (2021)

Upfront Bevacizumab and Temozolomide or Fotemustine before Radiotherapy for Patients with Glioblastoma and Severe Neurological Impairment at Diagnosis
por: Bihan, Celina, et al.
Publicado: (2012)

A prospective, multicentre, single-arm clinical trial of bevacizumab for patients with surgically untreatable, symptomatic brain radiation necrosis(†)
por: Furuse, Motomasa, et al.
Publicado: (2016)

Next Generation Sequencing-Based Transcriptome Predicts Bevacizumab Efficacy in Combination with Temozolomide in Glioblastoma
por: Adilijiang, Alimu, et al.
Publicado: (2019)

Role of bevacizumab therapy in the management of glioblastoma
por: Peak, Scott J, et al.
Publicado: (2010)

Bevacizumab for Glioblastoma—A Promising Drug or Not?
por: Nagane, Motoo, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_spd45q8pkp0t0q3mlb5urcao78